Envista Holdings Corp

Envista Holdings Corp

NVST
Envista Holdings CorpUS flagNew York Stock Exchange
24.07
USD
+0.25
- -
3.92BMarket Cap
Envista Holdings Corp
NVST
(New York Stock Exchange)

Recent

price

24.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
18.02
18.18
18.4
16.78
12.09
15.56
15.77
15.38
14.58
16.19
17.41
Revenue per Share
1.76
1.95
1.49
1.6
0.21
2.11
1.49
-0.6
-6.5
0.28
0.58
Basic EPS, GAAP
2.38
2.01
2.12
2.35
1.48
1.9
0.66
1.3
1.76
1.37
1.51
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
32.27
31.19
22.31
23.25
25.11
25.78
24.34
17.04
18.96
19.16
Book Value per Share
- -
0.68
0.69
-6.63
-4
-0.75
-2.31
-0.42
0.13
0.74
0.68
Tangible Book Value per Share
155
155
155
136
160
161
163
167
172
168
164
Basic Weighted Avg Shares
2,785
2,811
2,844
2,285
1,929
2,509
2,569
2,566
2,511
2,720
2,856
Sales/Revenue/Turnover
14.46
13.75
10.49
10.32
2.25
12.2
13.36
12.27
5.46
8.67
10.4
Operating Margin (%)
127
121
130
168
163
152
162
163
154
151
151
Depreciation Expense
272
301
231
218
33
340
243
-100
-1,119
47
95
Net Income, GAAP
32.29
22.14
23.38
21.22
- -
- -
16.17
- -
- -
73.48
59.42
Effective Tax Rate (%)
9.77
10.71
8.11
9.52
1.73
13.57
9.46
-3.9
-44.56
1.73
3.33
Profit Margin (%)
- -
166
146
293
-94
628
188
963
910
1,174
1,151
Working Capital
- -
- -
- -
1,507
1,060
1,004
992
1,508
1,397
1,559
1,550
LT Debt
- -
4,995
4,826
3,543
3,721
4,058
4,207
4,174
2,935
3,106
3,076
Total Equity
- -
12.04
4.66
3.75
- -
- -
5.09
- -
- -
1.35
2.54
Return on Invested Capital (%)
- -
12.06
4.7
4.45
- -
- -
4.89
- -
- -
1.23
2.33
Return on Capital (%)
- -
12.07
4.7
5.2
0.92
8.76
5.88
-2.39
-31.47
1.56
3.06
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
39
39
38
LT Borrowings
1,448
1,439
1,436
LT Finance Leases
110
111
113
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
164
163
161
Market Capitalization
3,556
4,133
4,232

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,027
1,919
1,958
Cash, Cash Equivalents & STI
1,212
1,083
1,126
Accounts Receivable, Net
430
437
437
Inventories
288
300
291
Total Current Liabilities
853
787
807
Payables & Accruals
252
238
250
ST Debt
39
39
38
Deferred Revenue
185
188
192

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-2.38%
5.84%
Free Cash Flow
- -
16.67%
-23.89%
Net Income, GAAP
- -
332.97%
-104.2%
Sales/Revenue/Turnover
- -
7.7%
8.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
624
633
601
653
2,511
2025
617
682
670
751
2,720
2026
706
730
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
-6.69
0.05
0.01
-6.5
2025
0.1
0.16
-0.18
0.2
0.28
2026
0.24
0.33
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.

Company News

  • Best Value Stocks to Buy for September 21st

  • Should Value Investors Buy Envista (NVST) Stock?

  • Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)

  • Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

  • Here's Why Envista (NVST) is a Strong Value Stock

  • Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript

  • NVST or ABT: Which Is the Better Value Stock Right Now?

  • Envista Announces Participation in Baird 2026 Global Healthcare Conference

  • Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?

  • Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More

  • Canada Pension Plan Investment Board Takes Position in Envista Holdings Corporation $NVST

  • 4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI

  • Best Momentum Stocks to Buy for August 27th

  • New Strong Buy Stocks for August 27th

  • Why Envista (NVST) is a Top Value Stock for the Long-Term

  • Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know

  • NVST or ABT: Which Is the Better Value Stock Right Now?

  • Do Options Traders Know Something About Envista Stock We Don't?

  • Best Value Stocks to Buy for August 24th

  • Deutsche Bank AG Takes $9.48 Million Position in Envista Holdings Corporation $NVST